Research
Molecular
Recent advancements in anti-obesity drugs allow for genotype-informed treatment options.
Practitioners can utilize genetic information to tailor obesity treatments.
StrongSupportsmedium confidence
With recent advancements in anti-obesity drugs, genetic studies pinpoint new targets and allow for repurposing existing drugs.
Why this rating
The claim is based on advancements and studies mentioned in the abstract.
Source
The complex web of obesity: from genetics to precision medicine
Janaki Nair M et al. · Expert Review of Endocrinology & Metabolism · 2024
DOI 10.1080/17446651.2024.2365785
reviewCited 1×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Molecular
- QRISK decreased markedly after weight loss from 18.9 ± 2.2% to 11.2 ± 1.6%, p < 0.0001.Strong
- Normalization of 10-year cardiovascular risk and heart age is possible after substantial dietary weight loss and remission of T2DM.Strong
- The Low-Fat Plus diet resulted in a greater reduction in total cholesterol compared to the Low-Fat diet, with changes of -0.46 mmol/L (-17.6 mg/dL) versus -0.24 mmol/L (-9.2 mg/dL) respectively (P = 0.01).Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →